|Day Low/High||207.18 / 212.58|
|52 Wk Low/High||160.08 / 260.63|
We want to nibble on Novartis, which is barely reacting to company-specific positive news.
Cloud-based cybersecurity companies ZScaler and CrowdStrike both jump after they announce a partnership that will provide businesses with real-time security protection across their computer networks.
Jim Cramer says it's amazing the market didn't fall on this oil shock. The U.S. is very different than it was a decade ago, he explains.
Jim Cramer takes a look at McDonald's, Ulta Beauty, DaVita, Coupa Software, Valley National Bancorp, Cliffs Natural Resources and more.
In line with our Three rating, we will use Monday's strength to exit our position in PANW.
Jim says after-hours action can be 'crazy' -- just look at what happened when Palo Alto Networks reported earnings.
Easing trade tensions and steepening yield curve add to bulls' optimism.
Stocks fell on manufacturing worries, but snapped back by the end of the week on renewed hopes for easing U.S.- China trade tensions.
Jim and Zev discuss UnitedHealth Group, Palo Alto Networks, Salesforce.com, the insider selling in Microsoft, and much more!
Earnings season may be winding down, there are still a few key companies reporting the week of September 2nd.
Stocks end sharply higher Thursday after officials from Washington and Beijing said they would resume trade talks in October.
While the security tech giant expects aggressive spending to weigh on its near-term profits, it's also forecasting strong revenue and billings growth through fiscal 2022.
Palo Alto's rally Thursday may not be the last. But the stock may fall slightly before resuming gains, one trader says.
The cybersecurity name fired off some punches at the competition and picked up another bolt-on acquisition amid earnings.
Palo Alto Networks stock holds gains but is fading from its post-earnings pop. Here are the must-know levels for PANW stock moving forward.
As the initial wild ride of PANW settles down, here are the stock's sweet spots.
Jim discusses his interview with Palo Alto Networks CEO Nikesh Arora, the CVS Health-Aetna merger settlement approval, Goldman Sachs and the Apple card, Novartis and more!
Jim Cramer gives his thoughts on Palo Alto Networks Earnings.
Management announced impressive targets over the next few years. But there are some overlooked aspects of this plan and its impact on Palo Alto as an investment.
Jim gives advice on how investors should deal with U.S.-China trade talks and breaks down Palo Alto Networks earnings.
What is clear is that both earnings and revenue growth, though still quite strong, are decelerating.
Analysts were largely encouraged by the road map management laid out.
Removal of this additional overhang should facilitate a shift in money flow back to CVS and make the stock far more appreciated.
Jim Cramer weighs in on the U.S.-China trade talks, Palo Alto Networks and the markets.
Billings, a key figure for cybersecurity companies, surprised to the upside as the company delivered more than was expected by analysts.
Palo Alto Networks shares shares traded sharply higher Thursday after the cybersecurity group posted stronger-than-expected fourth-quarter earnings and forecast a robust near-term outlook for its key product suite.
Shares of the provider of network security platforms could bump into a resistance zone after a strong start.
U.S. stock futures rise after officials from Washington and Beijing said they would resume trade talks in October; the ADP National Employment Report for August, a precursor to the official U.S. jobs report, will be released Thursday; Lululemon and Zoom Video report earnings; Slack sinks after indicating growth at the workplace messaging company will slow.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.